/Investor DB

Diamond Edge Ventures — 2025 Investments

2 investments dated 2025 · listed companies and verified rows first · show all

Licellalicella.cominJul 2025✓ verified

Licella is a developer of hydrothermal liquefaction technology that converts low-cost waste biomass into advanced biofuels, including sustainable aviation fuel (SAF), renewable diesel, and biomaterials.

BiotechCircular EconomyCleantechEnergyNorth Sydney, AU

Dr Len Humphreys(Executive Chairman)Professor Thomas Maschmeyer AO

TRIMTech Therapeuticstrimtechtherapeutics.cominSeed · Mar 2025 · $31M

TRIMTech Therapeutics is a biotechnology company focused on drug discovery and development, backed by investors including Cambridge Innovation Capital and BGF.

BiotechDeep TechLongevityMedical DevicesCambridge, GB

Damian Crowther, PhD FRCP(Co-founder, Head of Research)Dr. Leo James(Co-founder, Group Leader at MRC Laboratory of Molecular Biology)Dr. William McEwan(Co-founder, Group Leader at UK Dementia Research Institute, University of Cambridge)Nicki Thompson, PhD(CEO)Nicki Thompson(CEO)

Co-investorsCambridge Innovation CapitalPfizer VenturesSV Health InvestorsM VenturesPfizer Venture InvestmentsStart Codon

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.